###begin article-title 0
Regulatory network of inflammation downstream of proteinase-activated receptors
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Protease-activated receptors (PAR) are present in the urinary bladder, and their expression is altered in response to inflammation. PARs are a unique class of G protein-coupled that carry their own ligands, which remain cryptic until unmasked by proteolytic cleavage. Although the canonical signal transduction pathway downstream of PAR activation and coupling with various G proteins is known and leads to the rapid transcription of genes involved in inflammation, the effect of PAR activation on the downstream transcriptome is unknown.
###end p 3
###begin p 4
###xml 268 276 268 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 268 275 <span type="species:ncbi:562">E. coli</span>
We have shown that intravesical administration of PAR-activating peptides leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P (SP), and antigen was strongly attenuated by PAR1- and to a lesser extent by PAR2-deficiency.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 194 198 194 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 362 372 362 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
###xml 603 747 603 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2</italic>
###xml 753 760 753 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tnfaip2</italic>
###xml 998 1004 998 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp1 </italic>
###xml 1008 1015 1008 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nfkbia </italic>
###xml 1197 1212 1197 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arf6 and dcnt1 </italic>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
Here, cDNA array experiments determined inflammatory genes whose expression is dependent on PAR1 activation. For this purpose, we compared the alteration in gene expression in wild type and PAR1-/- mice induced by classical pro-inflammatory stimuli (LPS, SP, and antigen). 75 transcripts were considered to be dependent on PAR-1 activation and further annotated in silico by Ingenuity Pathways Analysis (IPA) and gene ontology (GO). Selected transcripts were target validated by quantitative PCR (Q-PCR). Among PAR1-dependent transcripts, the following have been implicated in the inflammatory process: b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2, and tnfaip2. However, a balanced response to signals of injury requires a transient cellular activation of a panel of genes together with inhibitory systems that temper the overwhelming inflammation. In this context, the activation of genes such as dusp1 and nfkbia seems to counter-balance the inflammatory response to PAR activation by limiting prolonged activation of p38 MAPK and increased cytokine production. In contrast, transcripts such as arf6 and dcnt1 that are involved in the mechanism of PAR re-sensitization would tend to perpetuate the inflammatory reaction in response to common pro-inflammatory stimuli.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
The combination of cDNA array results and genomic networks reveals an overriding participation of PAR1 in bladder inflammation, provides a working model for the involvement of downstream signaling, and evokes testable hypotheses regarding the transcriptome downstream of PAR1 activation.
###end p 8
###begin p 9
It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestation of cystitis.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1249 1251 1249 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1252 1254 1252 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1255 1257 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1258 1260 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 610 618 <span type="species:ncbi:9606">patients</span>
In general, inflammation plays a role in most bladder pathologies, including bladder cancer [1-4], and represents a defensive reaction to injury caused by physical damage, chemical substances, micro-organisms, or other agents [1,2]. In particular, neurogenic bladder inflammation involves the participation of mast cells and sensory nerves. We previously presented evidence indicating a key role for mast cells and their products in bladder inflammation [5-7]. As a consequence of inflammation, products of mast cell degranulation such as tryptase can be found in the urine of both bladder cancer and cystitis patients [8]. In addition to tryptase, other serine proteases such as thrombin and trypsin are produced during tissue damage and make important contributions to tissue responses to injury, repair, cell survival, inflammation [9-12], and pain [13-17]. Tissue responses to these enzymes are modulated by protease-activated receptors (PARs), a unique class of G protein-coupled receptors that use a fascinating mechanism to convert an extracellular proteolytic cleavage event into a trans-membrane signal. These receptors carry their own ligands, which remain cryptic until unmasked by receptor cleavage (for a review, please see references [13,16,18,19]).
###end p 11
###begin p 12
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
In order to better understand the role of PARs in cystitis, we used a well established mouse model [20-22] to determine the relative effect of PAR-specific peptide agonists. Comparison of inflammatory responses in wild type, PAR1- and PAR2-deficient mice, revealed a mandatory role of PAR1 and, to a lesser extent, PAR2 in mediating bladder responses to a variety of pro-inflammatory stimuli [23].
###end p 12
###begin p 13
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
###xml 252 257 <span type="species:ncbi:10090">mouse</span>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
###xml 367 371 <span type="species:ncbi:10116">rats</span>
Four PARs have been cloned to date, and all four PARs are co-expressed in the mouse bladder urothelium [24], with PAR2 and PAR3 being the most abundant in the bladder epithelial layer. In addition to the urothelium, PAR1 and PAR2 are also expressed in mouse detrusor muscle, and PAR4 is expressed in mouse peripheral nerves and plexus cell bodies [24]. Similarly, in rats PAR2, 3, and 4 are expressed in urothelium, detrusor muscle, and bladder nerve fibers, and bladder afferent cells in dorsal root ganglia express PAR2 to 4 [25]. Confocal microscopy has revealed the co-localization of PAR2, 3, and 4 with protein gene products 9.5 and vanilloid receptor 1, suggesting that PARs are distributed in C-fiber bladder nerves [25].
###end p 13
###begin p 14
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
###xml 653 656 <span type="species:ncbi:10116">rat</span>
In addition, PARs are differentially modulated during mouse bladder inflammation. Urothelial PAR2 and, to a lesser extent, PAR1 are down-regulated in acute inflammation, whereas PAR3 and PAR4 are up-regulated [24]. Bladder fibroblasts were found to present a clear demarcation in PAR expression in response to acute and chronic inflammation [24]. Additional evidence for the participation of PARs in the bladder inflammatory response was the finding that known pro-inflammatory stimuli such as LPS, substance P, and antigen challenge induce an increase in PAR4 RNA within four hours [20]. Upregulation of PAR protein levels has been shown to be part of rat bladder responses to cyclophosphamide [25]. Since PAR1 is well represented in the urinary bladder [24] and its expression is altered in bladder inflammation [24], we set forth to determine the molecular pathways downstream of PAR1 activation. For this purpose, we used a combination of gene-array technology, data mining using Ingenuity Pathways Analysis (IPA), and gene ontology (GO) annotation.
###end p 14
###begin p 15
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
The signal transduction pathway downstream of PAR activation and coupling with various G proteins is known and leads to the rapid transcription of genes involved in inflammation [13,26]. However, the exact composition of the transcriptome downstream of PAR activation remains to be determined. Our approach revealed a cascade of PAR1-dependent transcripts involved in apoptosis, cell death, cell cycle, cell growth and proliferation, cell motility, cell-cell interaction, gene expression, immune response, inflammation, renal and urologic development and disease, hematological disease, and cancer.
###end p 15
###begin p 16
###xml 35 45 35 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
The combination of cDNA arrays and in silico genomics network analysis reveals an overriding participation of PAR1 receptors in bladder inflammation, provides a working model for the involvement of downstream transcripts, and evokes testable hypotheses regarding the transcriptome downstream of PAR1 activation.
###end p 16
###begin title 17
Results
###end title 17
###begin title 18
Genes downstream of PAR1 activation
###end title 18
###begin p 19
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 252 253 252 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 475 476 475 476 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 581 582 581 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 585 586 585 586 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 676 677 676 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 684 689 684 689 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C-D- </bold>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
Seventy five genes fulfilled both the criteria of being expressed 3-fold higher after stimulation with SP or LPS and of not changing expression in response to the same stimuli of PAR1-/- mice, and were considered to be PAR1-dependent (Additional files 1 and 2, Table 1A and 1B). To further annotate this set of genes, we used a web-based entry tool developed by Ingenuity Pathways Analysis [IPA] [27]to query their knowledge database [27-29]. The resulting networks contain: A- Sub-cellular layout indicating the predominant location for the expression of encoded proteins (Figure 1); B-Analysis of canonical pathways significantly associated with this group of genes (Figure 2), and C-D- Biological functions across the entire dataset most significantly associated with this set of genes (Figure 3 and 4).
###end p 19
###begin title 20
###xml 30 31 30 31 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
Sub cellular location (Figure 1)
###end title 20
###begin p 21
###xml 384 390 384 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dctn1 </italic>
###xml 394 399 394 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arf6 </italic>
Genes (green) were associated with function (magenta) and localized to each compartment according to IPA and gene ontology. Dotted lines further group the genes by activity or function such as signal transduction, cytoskeleton re-organization and cell motility, carbohydrate metabolism, proteins and enzymes, transcription, and RNA editing. Of note, a particular set of genes such as dctn1 and arf6 are involved in PAR trafficking, and their function is associated with other PAR1-dependent transcripts with function in the cytoskeleton reorganization.
###end p 21
###begin title 22
###xml 68 69 68 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Participation of PAR1-dependent genes in canonical pathways (Figure 2)
###end title 22
###begin p 23
###xml 81 82 81 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 218 254 218 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">elk1, nfkbia, hspb1, dusp1, and akt2</italic>
###xml 410 416 410 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actg1 </italic>
###xml 420 424 420 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actb</italic>
Overall, PAR1-dependent transcripts belong to several canonical pathways (Figure 2). This type of IPA also revealed key genes that are significantly associated with more than one canonical pathway. This is the case of elk1, nfkbia, hspb1, dusp1, and akt2. In addition, this analysis indicates pathways such as VEGF and integrins which share common genes, as is the case of those encoding cytoskeleton proteins actg1 and actb.
###end p 23
###begin title 24
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 69 70 69 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
Primary functions associated with PAR1-dependent genes (Figure 3 and 4)
###end title 24
###begin p 25
###xml 8 9 8 9 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 14 15 14 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 582 600 582 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upk2, jundD, ptprc</italic>
###xml 606 615 606 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nfkbp1a) </italic>
###xml 687 689 687 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
Figures 3 and 4 represent biological functions significantly (p < 0.01) associated with PAR1-specific genes. Those included: apoptosis (n = 26 genes); cell death (n = 29); cell survival (n = 10); cancer (n = 29); cellular growth and proliferation (n = 29); cell-to-cell signaling (n = 15); hematological disease (n = 9); cellular movement (n = 16); gene expression (n = 18); immune and lymphatic system development and function (n = 9); immune response/disease (n = 19); and inflammation and inflammatory disease (n = 22). This type of analysis also revealed PAR-1 dependent genes (upk2, jundD, ptprc, and nfkbp1a) encoding proteins associated with renal and urological diseases. Figure 1D also indicates common pathways of PAR1-dependent transcripts shared by inflammation (red) and cancer (green) and revealed possible targets uniquely associated with some of the biological functions.
###end p 25
###begin title 26
Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-based assays
###end title 26
###begin p 27
###xml 139 158 139 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam-3, dctn1, elk1</italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp2</italic>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pla2G1b</italic>
###xml 615 706 615 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actb, akt2, arf6, ccl7, cd63, dusp1, fkbp1a, nfkbia, phlda1, plaur, s100a10, tnfaip3, ube2h</italic>
###xml 712 716 712 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upk2</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
Of the 19 genes tested by Q-PCR analysis of CHIP isolated from wild type mice challenged with control peptide, PAR1- and PAR2-AP, 4 genes (adam-3, dctn1, elk1, and mmp2) had their control levels 1.5 times below background (un-transcribed region) and, therefore, their results are not being presented. Results are presented in figure 5 as averaged Transcription Events Detected Per 1000 Cells for each gene tested and their standard deviations. With the exception of pla2G1b, these results indicate that treatment of wild type mice with PAR1- and PAR2-AP induced up-regulation of the following PAR1-dependent genes: actb, akt2, arf6, ccl7, cd63, dusp1, fkbp1a, nfkbia, phlda1, plaur, s100a10, tnfaip3, ube2h, and upk2.
###end p 27
###begin title 28
###xml 41 43 41 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
PAR-activation of calcium independent PLA2 (figures 6 and 7)
###end title 28
###begin p 29
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pla2G1b </italic>
###xml 77 79 77 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 287 289 287 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 294 295 294 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 558 560 558 560 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 966 967 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1030 1031 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1095 1096 1095 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1314 1315 1314 1315 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
###xml 1250 1255 <span type="species:ncbi:10090">mouse</span>
Our cDNA array results indicate that pla2G1b encoding a calcium-dependent PLA2 was a PAR1-dependent transcript. However, this particular transcript was not validated by Q-PCR of actively-transcribed DNA (Figure 5). Because of the prominent role of the calcium-independent phospholipase A2 (iPLA2) in mediating tryptase-activated PAR in bladder microvascular endothelial cells [30], bladder urothelial cells [31,32], and PAR2-AP in bladder contractions [33], we decided to determine whether bladder instillation with PAR-APs also induced up-regulation of iPLA2 in the mouse bladder mucosa. The rationale for using only the mucosa was to decrease the complexity of the bladder system, getting closer to the urothelial cell in culture used by the other authors [31,32]. For this purpose, cytoplasmic extracts from the bladder mucosa of WT mice instilled with PAR-APs- or control peptide- were subjected to Western Blot analysis to measure relative concentration of iPLA2. Results are representative of 4 separate experiments (Figure 6). The bar graph shows the average densitometric values (Figure 7). When data was normalized with beta-actin used as loading control, the same relationship was observed (data not shown). These data indicate that in the mouse urinary bladder, all PAR-APs induced up-regulation of iPLA2.
###end p 29
###begin title 30
Discussion
###end title 30
###begin p 31
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
Serine proteases that originate from the circulation (coagulation factors), inflammatory cells (mast cell tryptase, neutrophil granzyme A, and proteinase 3), and epithelial and neuronal tissues (trypsins) can specifically regulate cells by cleaving PARs [34]. Proteases cleave PARs to reveal tethered ligand domains that bind to and activate the cleaved receptors. The proteases that activate PARs are often generated and secreted during injury and inflammation, and PARs orchestrate tissue responses to these insults, including hemostasis, inflammation, nociception, and repair mechanisms [34].
###end p 31
###begin p 32
###xml 846 848 846 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
The present results indicated fundamental alterations elicited by pro-inflammatory substances (LPS and SP) in bladder gene-regulation that are mediated by activation of PAR1. The possible mechanisms by which LPS and SP induce PAR activation include degranulation of mast cells with a concomitant release of tryptase and plasma extravasation leading to accumulation of products of the coagulation cascade that activate PARs. However, the activation of PAR in the physiological state is more complex. Although thrombin is a recognized physiological activator of PAR1 and PAR4, the endogenous enzymes responsible for activating PAR2 in urinary bladder are not known. Recently, it was demonstrated that tissue kallikrein family of proteinases are able to regulate PAR signaling and may represent important endogenous regulators PAR1, PAR2, and PAR4 [35]. Interestingly, the kallikrein family plays a fundamental role in bladder physiology [36].
###end p 32
###begin title 33
Transcriptional alteration downstream PAR activation
###end title 33
###begin p 34
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 421 431 421 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in silico </italic>
In terms of mechanism of action, it is well established that after stimulation, PARs couple to various G proteins and activate signal transduction pathways resulting in the rapid transcription of genes that are involved in inflammation [13,26,34,37]. However, the response of the transcriptome downstream of PAR activation is not known. Here, we used an approach involving the combination of cDNA arrays, CHIP assay, and in silico querying of knowledge databases in order to identify functions dependent of PAR1 activation that are modified during bladder inflammation. Although we clearly defined the criterion for a gene to be named PAR1-dependent (see Methods section), the expression of some/many of these genes may only be indirectly dependent on PAR-1, due to the nature of the downstream cascades and interacting pathways.
###end p 34
###begin p 35
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1044 1046 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1145 1146 1145 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1208 1209 1208 1209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1211 1212 1211 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1214 1215 1214 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
The use of cDNA arrays has contributed immensely to the understanding of inflammation, in general, and the bladder inflammatory transcriptome, in particular [7,20,21,38-41]. In addition, the use of curated networks such as the Ingenuity Pathways Analysis leads to a comprehensive integration of how PAR1-dependent transcripts correlate with canonical pathways and known biological functions. Because our results were obtained with whole bladders, it is not clear whether any single network may be operative in a particular cell type. However, this approach can potentially identify previously unrecognized connections among pathways and, therefore, suggests new hypotheses for the mechanisms of bladder inflammation. Therefore, the value of our approach is to raise testable hypotheses that can be tested in isolated cells or in individual bladder layers. Aberrant expression of protease-activated receptors (PARs) has been associated not only with inflammation but with increased angiogenesis, tumor growth, and metastasis of various cancers [42-47]. Therefore, our approach outlined a global visualization of PAR-dependent transcripts (Figure 1) as well as their interaction with several pathways (Figures 2, 3, 4).
###end p 35
###begin p 36
###xml 129 273 129 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2</italic>
###xml 279 287 279 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tnfaip2)</italic>
###xml 355 377 355 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">wnt6, wisp2, and dvl3 </italic>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WNT </italic>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd200</italic>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 800 806 800 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nfkbia</italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 430 435 <span type="species:ncbi:9606">human</span>
Our results indicated that several genes known to be part of the inflammatory response were found downstream of PAR1 activation (b2m, ccl7, cd200, cd63, cdbpd, cfl1, dusp1, fkbp1a, fth1, hspb1, marcksl1, mmp2, myo5a, nfkbia, pax1, plaur, ppia, ptpn1, ptprcap, s100a10, sim2, and tnfaip2). The present work adds to this list pro-inflammatory genes such as wnt6, wisp2, and dvl3 that belong to the WNT family known to be altered in human interstitial cystitis [48,49]. In contrast, some of the proteins encoded by PAR1-dependent transcripts play a role in shutting down the inflammatory cascade. This is the case with type-1 membrane glycoprotein encoded by Cd200, which delivers an inhibitory signal cancelling the inflammation-induced macrophage activation [50]. Within this group, we also highlight nfkbia, which encodes IkappaB-alpha, an inhibitor of the NF-kappaB cascade [51,52].
###end p 36
###begin p 37
###xml 87 99 87 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tetraspanin </italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cd63</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">adam3</italic>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cd63 </italic>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 459 471 459 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Uroplakin 2 </italic>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 842 844 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 969 976 969 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se </italic>
In addition to genes involved in inflammation, we found upregulation of members of the tetraspanin family (cd63, and adam3) and upk2 that dimerises with the tetraspanin uroplakin 1a. Cd63 encodes a protein localized in the membrane of mast cells [53], and anti-CD63 antibodies inhibit mast cell adhesion to fibronectin and vitronectin [53]. Adam-3 may have a role in inflammation by regulating the expression of allograft inflammatory factor-1 and iNOS [54]. Uroplakin 2 is a major component of the surface plaques of the urothelium [55], is found exclusively in differentiated mammalian urothelium [56], and is a product of terminally-differentiated apical cell layer [57,58]. In addition to differentiation, uroplakins play a fundamental role in the bladder permeability barrier [59], wound healing [60], bacterial adherence and infection [61], and possibility bladder inflammation [62]. The present results are the first direct evidence indicating that inflammation per se alters the message for uroplakin 2.
###end p 37
###begin p 38
###xml 107 108 107 108 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 561 563 561 563 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 568 569 568 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 600 602 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 940 942 940 942 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 198 202 <span type="species:ncbi:10090">mice</span>
###xml 975 979 <span type="species:ncbi:10090">mice</span>
Among the secreted enzymes regulated by PAR1-dependent transcripts is the calcium-dependent phospholipase A2, group IB that was up-regulated by LPS- and SP-induced bladder inflammation in wild type mice. Our Q-PCR results did not confirm an up-regulation of transcription in response to PAR1-AP and PAR2-AP. There are several explanations for this discrepancy. One possibility is that the differential expression of RNA was not due to active transcription and therefore, reflects RNA processing. As others have shown that the calcium independent phospholipase A2 (iPLA2) mediates bladder urothelial [31], microvascular [30], and smooth muscle [33] responses to PAR activation, and has a role in promoting mmp-2-induced cell migration via the phosphatidylinositol 3-kinase - Akt pathway [63], we went further to test whether this calcium-independent PLA is also up-regulated in response to PAR-APs. Our results confirmed upregulation of iPLA2 protein in the bladder mucosa of mice instilled with PAR-APs, supporting the upregulation of message levels.
###end p 38
###begin p 39
###xml 99 121 99 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">plaur, actR-IIb, dusp1</italic>
###xml 127 139 127 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">akt2. Plaur </italic>
###xml 196 212 196 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">(u-PA receptor) </italic>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plaur </italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 440 446 440 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp1 </italic>
###xml 591 593 591 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 598 604 598 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp1 </italic>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 731 736 731 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Akt2 </italic>
###xml 934 939 934 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Akt2 </italic>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 964 969 964 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Akt2 </italic>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1262 1264 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1270 1272 1270 1272 <sub xmlns:xlink="http://www.w3.org/1999/xlink">i </sub>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1304 1306 1304 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
Another group of genes encodes proteins with roles in signal transduction pathways. Those include: plaur, actR-IIb, dusp1, and akt2. Plaur encodes the receptor for urokinase plasminogen activator (u-PA receptor) and promotes plasmin formation [64]. Plaur is most closely associated with cancer invasion [65]. A strong correlation exists between PAR mediating the response of thrombin and u-PAR-mediated cancer cell migration/invasion [42]. Dusp1 encodes a dual specificity phosphatase 1 or mitogen-activated protein kinase [MAPK] phosphatase 1, which dephosphorylates and inactivates MAPKs [66,67].Dusp1 regulates a subset of LPS-induced genes [68] and modulates the anti-inflammatory effects of dexamethasone in macrophages [66]. Akt2 is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. Others have shown that thrombin and PAR- APs induce Akt2 phosphorylation [69,70]. Akt2 is a general protein kinase capable of phosphorylating several known proteins and, therefore, occupies a central position in several signal transduction pathways (Figures 1B and 1C). Moreover, PAR activation in platelets leads to Akt2 phosphorylation by a mechanism involving either G(12/13) [69] or Gi [71] and Src kinase activation [69].
###end p 39
###begin p 40
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 381 422 381 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mid2, ubr1, pxmp3, ube2h, cul3, and skp1a</italic>
###xml 576 582 572 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ube2h </italic>
###xml 629 631 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 794 796 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
The process of desensitization and re-sensitization of PA receptors is being elucidated [72]. Agonists of PARs induce an irreversible activation by proteolytic cleavage of the tethered ligand peptides and rapid receptor endocytosis that are targeted to lysosomes [73,74]. Interestingly, among the PAR1-dependent transcripts, the following encode proteins of the ubiquitin pathway: mid2, ubr1, pxmp3, ube2h, cul3, and skp1a. Little is known regarding the alteration of expression of this set of genes during inflammation. However, it has been reported that TNFalpha stimulates ube2h expression by a mechanism involving NF-kappaB [75]. Together these results raised the intriguing hypothesis that inflammation can induce an increase in the ubiquitin pathway that also modulates the fate of PARs [76].
###end p 40
###begin p 41
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Rab </italic>
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 100 106 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dcnt1 </italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arf6 </italic>
###xml 187 193 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dcnt1 </italic>
###xml 257 262 257 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rab6 </italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arf6 </italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARF</italic>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 539 541 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 544 549 544 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arf6 </italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 663 668 663 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arf6 </italic>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 779 784 779 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arf6 </italic>
###xml 953 955 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 397 402 <span type="species:ncbi:9606">human</span>
The Rab family of proteins play a fundamental role in PAR re-sensitization [77]. Here, we show that dcnt1 and arf6 also involved in PAR trafficking and are increased during inflammation. Dcnt1 is a subunit of the dynein/dynactin complex and an effector for rab6 [78]. This protein is required for the retrograde movement of vesicles and organelles along microtubules [79]. Arf6 is a member of the human ADP-ribosylation factor (ARF) family of proteins belonging to the Ras superfamily of small GTPase implicated in vesicle trafficking [80-82]. Arf6 participates in the endosomal pathway that regulates endocytosis of several receptors [83]. Post-internalization, arf6 and other membrane components are recycled back to the cell surface [80]. In addition to membrane trafficking, arf6 cellular functions include: actin remodeling, cell adhesion, redistribution of beta1 integrins, phagocytosis, cell division, and tumor-cell invasion (for a review, see [80]).
###end p 41
###begin p 42
###xml 38 40 38 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
As alterations in PAR density itself [25] or in the mechanisms involved in re-sensitization of these receptors can have strong consequences in the shift between homeostasis and inflammation, our results raise the intriguing hypothesis that, in contrast to PAR endocytosis and cessation of the stimulus that occurs during normal physiological responses, inflammation may lead to increased re-cycling of PARs back to the plasma membrane and, therefore, perpetuation of the signal transduction downstream of PAR activation.
###end p 42
###begin p 43
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mmp2 </italic>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 538 539 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
Although the classification by biological function permits a visual association of genes and cellular processes (Figure 1), it has the disadvantage of over simplification because several genes may belong to more than one group. This is the case of mmp2 (gelatinase A) that is involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes such as inflammation and cancer. Therefore, we constructed figures 2, 3, and 4 in order to illustrate common pathways involving PAR1-dependent transcripts. This type of association analyses permits the identification of new pathways such as the interaction of PAR1-dependent transcripts with the VEGF-family of growth factors, and suggests explanations of an active role of PAR in angiogenesis [45,84-86]. Together, the pathway analysis revealed relevant target for therapeutic interventions to control or to prevent disease progression and bladder inflammation.
###end p 43
###begin title 44
Other cDNA array analysis
###end title 44
###begin p 45
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 571 577 571 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp1 </italic>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 117 122 <span type="species:ncbi:9606">human</span>
We are aware of a single publication investigating genes downstream of PAR1 activation. This work was performed in a human endothelial cell line challenged with thrombin with the aim of identifying early genes and comparing to those up-regulated in response to leukotriene D4 [87]. Unfortunately, the referred work did not provide GenBank accession numbers for the PAR1 activated transcripts, which makes comparisons of the results to the current study difficult. Nevertheless, some similarities could be found between their work and the present one. This is the case of dusp1 that was found upregulated in both manuscripts. In addition we found adam3, whereas Uzonyi, et al. found another disintegrin-like metalloprotease (adamts1) [87].
###end p 45
###begin title 46
Conclusion
###end title 46
###begin p 47
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dusp1 </italic>
###xml 318 325 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nfkbia </italic>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 512 527 512 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arf6 and dcnt1 </italic>
###xml 1029 1031 1029 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B88">88</xref>
This work indicates an overriding participation of PAR1 receptors in bladder inflammation, provides a working model for the involvement of a network of transcripts downstream of PAR1 activation, and evokes testable hypotheses regarding the regulation of PAR. In this context, the activation of genes such as dusp1 and nfkbia seems to counter balance the inflammatory response to PAR activation by avoiding prolonged activation of p38 MAPK and increased cytokine production [68]. In contrast, transcripts such as arf6 and dcnt1 that are involved in the mechanism of receptor re-sensitization would tend to perpetuate the inflammatory reaction. It remains to be determined whether PAR1 receptor blockade or selective gene silencing transcripts downstream of PAR activation will ameliorate the clinical manifestation of cystitis. Inhibiting of PAR up-regulation using small interfering RNA technology, as confirmed by immunoblotting, should substantially reduced bladder inflammatory response as it has been shown in other systems [88].
###end p 47
###begin title 48
Methods
###end title 48
###begin title 49
Animals
###end title 49
###begin p 50
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 308 312 308 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 134 139 <span type="species:ncbi:9606">Human</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
All animal experimentation described here was performed in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" (OUHSC Animal Care & Use Committee protocol #05-088I). PAR1-/-[89] and C57BL/6J mice were used in this research. C57BL/6J mice were used as wild type since PAR1-/- was enriched in this background.
###end p 50
###begin title 51
Induction of cystitis
###end title 51
###begin p 52
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 77 79 77 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 511 528 509 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 511 527 <span type="species:ncbi:562">Escherichia coli</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1007 1011 <span type="species:ncbi:10090">mice</span>
Acute cystitis was induced in groups of mice, as we described previously [20-22,24,40]. Briefly, female wild type (C57BL/6J), and PAR-1-/- mice were anesthetized (ketamine 200 mg/kg and xylazine 2.5 mg/kg, i.p.), then transurethrally catheterized (24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah), and the urine was drained by applying slight digital pressure to the lower abdomen. The urinary bladders were instilled with 200 mul of one of the following substances: pyrogen-free saline, SP (10 muM), or Escherichia coli LPS strain 055:B5 (Sigma, St. Louis, MO; 100 mug/ml). Substances were infused at a slow rate to avoid trauma and vesicoureteral reflux (18). To ensure consistent contact of substances with the bladder, infusion was repeated twice within a 30-min interval, and a 1-ml tuberculin syringe was maintained on the catheter to retain the intravesical solution for 1 hour. After that the catheter was removed and mice were allowed to void normally. Twenty-four hours after instillation, mice were euthanized with pentobarbital (200 mg/kg, i.p.) and bladders removed rapidly.
###end p 52
###begin title 53
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
Minimum information about microarray experiments - MIAME [90]
###end title 53
###begin title 54
Objective
###end title 54
###begin p 55
###xml 142 146 142 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
To determine the time course of gene-expression in urinary bladders in response to saline, SP, or LPS, challenge of wild type control and PAR1-/- mice.
###end p 55
###begin title 56
Array design
###end title 56
###begin p 57
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B91">91</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 51 54 <span type="species:ncbi:9685">Cat</span>
Mouse plastic 5 K Arrays (Clontech, Palo Alto, CA, Cat. #634809). For a complete list of genes present in this array see reference [91].
###end p 57
###begin title 58
Animal numbers
###end title 58
###begin p 59
###xml 18 22 18 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 71 88 70 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 71 87 <span type="species:ncbi:562">Escherichia coli</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
Female WT and PAR1-/- mice were instilled with saline, SP (10 muM), or Escherichia coli LPS strain 055:B5 (Sigma, St. Louis, MO; 100 mug/ml). One group of mice was euthanized at 4 and another at 24 hours following stimulation, the urinary bladders were removed from all groups (n = 8) for RNA extraction.
###end p 59
###begin title 60
Sample preparation for cDNA expression arrays
###end title 60
###begin p 61
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 245 250 <span type="species:ncbi:10090">Mouse</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
We used the same technology as we described before [6,20,21,39,40]. Briefly, eight bladders from each group were homogenized together in Ultraspec RNA solution (Biotecx Laboratories Inc. Houston, TX) for isolation and purification of total RNA. Mouse bladders were pooled to ensure enough RNA for gene array analysis. The justification for this approach is that there is not enough RNA in a single mouse bladder for performing cDNA array experiments and the step of purification reduces the amount of total RNA. RNA was DNase-treated according to manufacturer's instructions (Clontech Laboratories, Palo Alto, CA), and the quality of 10 mug was evaluated by denaturing formaldehyde/agarose gel electrophoresis.
###end p 61
###begin title 62
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse cDNA expression arrays
###end title 62
###begin p 63
###xml 183 185 178 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">33</sup>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
cDNA probes were prepared from DNase-treated RNAs obtained from each of the experimental groups. Five mug of DNase-treated RNA was reverse-transcribed to cDNA and labeled with [alpha-33P]dATP, according to the manufacturer's protocol (Clontech, Palo Alto, CA). The radioactively labeled complex cDNA probes were hybridized overnight to Atlastrade mark mouse plastic 5 K arrays (Clontech, Palo Alto, CA) using ExpressHybtrade mark hybridization solution with continuous agitation at 68 degreesC. After two high-stringency washes, the hybridized membranes were exposed (at room temperature) to a ST Cyclone phosphor screen overnight. Spots on the arrays were quantified by BD AtlasImagetrade mark 2.7 software (Clontech, Palo Alto, CA).
###end p 63
###begin title 64
PAR1-dependent genes. Both the 4 hour and 24 hour time points after inflammation were used to define PAR1-dependent genes
###end title 64
###begin p 65
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 258 262 258 262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 330 333 330 333 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 545 548 545 548 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 577 581 577 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
Data was normalized by a robust linear regression analysis using only genes expressed above background, as described [7,20,39,40], and the ratio of gene-expression between LPS- and SP-, and saline-challenge was obtained at 4 and 24 hours post-challenge. PAR1-/- dependent genes were selected according to the following criterion: A. In tissues isolated from WT mice, the expression of particular gene should be up-regulated (ratio between LPS- or SP- and saline-treated > 3.0) in at least one of the time points (4 and 24 hours post-challenge); B. in tissues isolated from PAR1-/- mice, the expression of same gene should not be altered in response to LPS or SP in any of the time points.
###end p 65
###begin title 66
Database submission of microarray data
###end title 66
###begin p 67
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
The microarray data have been deposited in the Gene Expression Omnibus (GEO) database [92]. The samples can be retrieved with GEO accession numbers: GSM144550, GSM144551, GSM144552, GSM144553, GSM144554, GSM144555, GSM144556, GSM144557, GSM144558, GSM144559 that are included in a series (accession number GSE6286).
###end p 67
###begin title 68
Development of the observed interactome of PAR1-specific genes
###end title 68
###begin p 69
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 571 573 571 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 780 782 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
Ingenuity Pathways Analysis [IPA], (Ingenuity Systems, Mountain View, CA) is a robust and expertly curated database containing up-to-date information on over 20,000 mammalian genes and proteins, 1.4 million biological interactions, and one hundred canonical pathways incorporating over 6,000 discreet gene concepts. This information is integrated with other relevant databases such as EntrezGene and Gene Ontology [29]. IPA computes a score for each network according to the fit of the set of supplied focus genes (here, PAR1-dependent genes). These scores, derived from p values, indicate the likelihood of focus genes to belong to a network versus those obtained by chance. A score > 2 indicates a </= 99% confidence that a focus gene network was not generated by chance alone [93]. The experimental datasets of PAR1-dependent genes was used to query the IPA and to compose a set of interactive networks taking into consideration canonical pathways, the relevant biological interactions, and the cellular and disease processes.
###end p 69
###begin title 70
Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-based assays
###end title 70
###begin p 71
###xml 514 516 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 565 567 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 588 590 587 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B94">94</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 949 953 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
Target validation was sought for 19 of the genes identified from the microarray data as being PAR1-dependent. Female C57BL/6J mice (n = 20 per group) were anesthetized (ketamine 200 mg/kg and xylazine 2.5 mg/kg, i.p.), then transurethrally catheterized (24 Ga.; 3/4 in; Angiocath, Becton Dickson, Sandy, Utah), and the urine was drained by applying slight digital pressure to the lower abdomen. The urinary bladders were instilled with 200 mul of one of the following substances: control inactive peptide (LRGILS [94]) or PAR-activating peptides (PAR1-AP = SFFLRN [94]; PAR2-AP = SLIGRL [94]). Substances were infused at a slow rate to avoid trauma and vesicoureteral reflux (18). To ensure consistent contact of substances with the bladder, infusion was repeated twice within a 30-min interval, and a 1-ml tuberculin syringe was maintained on the catheter end to retain the intravesical solution for 1 hour. After that the catheter was removed and mice were allowed to void normally. Twenty-four hours after instillation, mice were euthanized with pentobarbital (200 mg/kg, i.p.) and bladders removed rapidly and frozen.
###end p 71
###begin p 72
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B96">96</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B97">97</xref>
Frozen bladders were shipped to Genpathway [95] for querying the chromatin for transcription of specific genes (Genpathway's TranscriptionPath Query assay) [96]. Bladders were exposed briefly to formaldehyde for cross-linking of the proteins and DNA together, followed by sonication to fragment the DNA into pieces of approximately 300-500 bp. An antibody against RNA polymerase II (Abcam) was then used to precipitate the DNA transcriptome. The Ab-protein-DNA complexes were purified using beads coupled to protein A. The DNA was isolated from the complexes using a combination of heat to reverse cross-linking, RNase and proteases, and then purified using phenol extraction and EtOH precipitation. The final CHIP DNAs were then used as templates for Q-PCR reactions using primer pairs specific for each gene of interest. Q-PCR was carried out using Taq polymerase (iQ SYBR Green Supermix, Bio-Rad). Primer pairs were designed using Primer 3 [97]. Details of the primer sequences and the Genebank accession numbers are given in additional material 2 (Table 2). The designed primers shared 100% homology with the target sequence but no significant homology with other sequences.
###end p 72
###begin p 73
Q-PCRs were run in triplicate and the averaged Ct values were transferred into copy numbers of DNA using a standard curve of genomic DNA with known copy numbers. The resulting transcription values for each gene were also normalized for primer pair amplification efficiency using the Q-PCR values obtained with Input DNA (unprecipitated genomic DNA). Results are presented as Transcription Events Detected Per 1000 Cells for each gene tested.
###end p 73
###begin title 74
Tissues for Western Blotting
###end title 74
###begin p 75
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Twenty-four hours post-instillation, bladders were rapidly removed and placed in ice cold PBS with protease inhibitors (Complete Protease Inhibitor, Roche, Indianapolis, IN) on ice where the mucosa was dissected away from the detrusor smooth muscle, as described [32]. Tissues were flash frozen and stored at -80 C until processing. Tissues were pulverized in a spring-loaded tissue pulverizer (Bio-Pulverizer, Biospec Products, Bartlesville, OK) and chilled with liquid nitrogen. Cytosolic extracts were prepared using the Pierce NE-PER Kit that enables stepwise separation and preparation of cytoplasmic and nuclear extracts from bladder tissue. Addition of the first two reagents (Pierce's proprietary information) to the pulverized tissue causes disruption of cell membranes and release of cytoplasmic contents. After recovering the intact nuclei from the cytoplasmic extract by centrifugation at 16,000 x g for 5 minutes, the nuclei are lysed with a third reagent (Pierce's proprietary information) to yield the nuclear extract. Extracts obtained with this product generally have less than 10% contamination between nuclear and cytoplasmic fractions-sufficient purity for most experiments involving nuclear extracts. A western blot was prepared using the nuclear and cytosolic extracts and probed for the nuclear proteins histone H3 and lamin A/C. No nuclear contamination was shown in the cytosolic fractions (data not shown). Protein concentrations were determined with a Micro BCA Kit (Pierce, Rockford, IL) per manufacturer's instructions.
###end p 75
###begin title 76
Western Blot
###end title 76
###begin p 77
###xml 431 433 429 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 867 869 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B98">98</xref>
###xml 415 421 <span type="species:ncbi:9986">rabbit</span>
###xml 522 528 <span type="species:ncbi:9986">rabbit</span>
Immunoblot analyses were performed using 15 mug cytosolic extract loaded onto a 10% tris-glycine SDS gel and run at 125 V for 1.5 hours in tris-glycine SDS running buffer (BioRad, Hercules, CA). The proteins were then transferred to a 0.45 mum nitrocellulose membrane in 1/2 x tris-glycine SDS running buffer with 20% methanol using a BioRad Mini-TransBlot Cell. After blocking in 2% BSA, blots were incubated with rabbit anti-iPLA2 (Cayman Chemical, Ann Arbor, MI) at 1:500 overnight at 4degreesC. An HRP-conjugated anti-rabbit secondary antibody was used for detection at 1:10,000 (Santa Cruz Biotechnology, Santa Cruz, CA) and an enhanced chemiluminescent detection kit (Chemiglow West, Alpha Innotech, San Leandro, CA) was used to visualize. Images were taken using the FluorChem HD digital darkroom (Alpha Innotech, San Leandro, CA) and quantified using ImageJ [98].
###end p 77
###begin title 78
Materials
###end title 78
###begin p 79
PAR-AP - PAR1-, PAR2-, and PAR4-AP were synthesized at Molecular Biology Resource Facility, William K. Warren Medical Research Institute, OUHSC, as carboxyl-terminal amides, purified by high-pressure liquid chromatography, and characterized by mass spectroscopy. Peptide solutions were made fresh from powder for most experiments. PAR3-AP was not used in this research because of lack of specificity.
###end p 79
###begin title 80
Competing interests
###end title 80
###begin p 81
The author(s) declare that they have no competing interests.
###end p 81
###begin title 82
Authors' contributions
###end title 82
###begin p 83
###xml 52 55 52 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RS </bold>
###xml 106 110 106 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MRD </bold>
###xml 177 181 177 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PAG </bold>
###xml 238 242 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 250 254 250 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 260 264 260 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CKD </bold>
###xml 314 317 314 317 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ID </bold>
###xml 375 378 375 378 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MI </bold>
###xml 441 445 441 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">REH </bold>
###xml 508 511 508 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CS </bold>
###xml 562 566 562 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MRS </bold>
###xml 595 599 595 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink">MRS </bold>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
All authors read and approved the final manuscript. RS conceived of the study and drafted the manuscript, MRD participated in the design and reviewed the morphological results, PAG participated in the experimental design and provided PAR1-/- and PAR2-/- mice, CKD participated in design and proper use of PAR-APS, ID performed the statistical analysis of microarray results, MI participated in its design and helped to draft the manuscript, REH participated in its design and helped to draft the manuscript, CS performed the western blotting analysis and helped MRS with animal experiments, and MRS participated in its design, carried out the animal experiments, removed the tissues, and performed gene array experiments.
###end p 83
###begin title 84
Supplementary Material
###end title 84
###begin title 85
Additional file 1
###end title 85
###begin p 86
PAR1-Dependent Transcripts. Table 1
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional file 2
###end title 88
###begin p 89
Primers for Q-PCR. Table 2
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Acknowledgements
###end title 91
###begin p 92
Supported by National Institutes of Health grants DK 55828-01 and DK066101-01 (R.S.).
###end p 92
###begin article-title 93
###xml 156 164 <span type="species:ncbi:9606">patients</span>
The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladder
###end article-title 93
###begin article-title 94
Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma
###end article-title 94
###begin article-title 95
The pharmacogenetic impact of inflammatory genes on bladder cancer recurrence
###end article-title 95
###begin article-title 96
Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis
###end article-title 96
###begin article-title 97
Lack of neurokinin-1 receptor expression affects tissue mast cell numbers but not their spatial relationship with nerves
###end article-title 97
###begin article-title 98
Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism
###end article-title 98
###begin article-title 99
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Mast cell regulation of inflammation and gene expression during antigen-induced bladder inflammation in mice
###end article-title 99
###begin article-title 100
###xml 167 175 <span type="species:ncbi:9606">patients</span>
Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients
###end article-title 100
###begin article-title 101
A role for proteinase-activated receptor-1 in inflammatory bowel diseases
###end article-title 101
###begin article-title 102
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Proteinase-activated receptor-2-induced colonic inflammation in mice: possible involvement of afferent neurons, nitric oxide, and paracellular permeability
###end article-title 102
###begin article-title 103
Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway
###end article-title 103
###begin article-title 104
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
###end article-title 104
###begin article-title 105
Protease-activated receptors: contribution to physiology and disease
###end article-title 105
###begin article-title 106
Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia
###end article-title 106
###begin article-title 107
###xml 83 93 <span type="species:ncbi:10141">guinea pig</span>
Mast cell tryptase and proteinase-activated receptor 2 induce hyperexcitability of guinea pig submucosal neurons
###end article-title 107
###begin article-title 108
Protease-activated receptors in inflammation, neuronal signaling and pain
###end article-title 108
###begin article-title 109
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
###end article-title 109
###begin article-title 110
International Union of Pharmacology. XXVIII. Proteinase-Activated Receptors
###end article-title 110
###begin article-title 111
Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology
###end article-title 111
###begin article-title 112
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation
###end article-title 112
###begin article-title 113
Gene expression profiling of inflammatory bladder disorders
###end article-title 113
###begin article-title 114
LPS-sensory peptide communication in experimental cystitis
###end article-title 114
###begin article-title 115
Mandatory Role of Proteinase-Activated Receptor 1 in Experimental Bladder Inflammation
###end article-title 115
###begin article-title 116
###xml 99 104 <span type="species:ncbi:10090">mouse</span>
Expression of protease-activated receptor-1, -2, -3, and -4 in control and experimentally inflamed mouse bladder
###end article-title 116
###begin article-title 117
Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers
###end article-title 117
###begin article-title 118
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
###end article-title 118
###begin article-title 119
###xml 53 59 <span type="species:ncbi:9606">humans</span>
A network-based analysis of systemic inflammation in humans
###end article-title 119
###begin article-title 120
website
###end article-title 120
###begin article-title 121
Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells
###end article-title 121
###begin article-title 122
###xml 38 43 <span type="species:ncbi:9606">human</span>
Phospholipid metabolite production in human urothelial cells after protease-activated receptor cleavage
###end article-title 122
###begin article-title 123
Stimulation of protease activated receptors on RT4 cells mediates arachidonic acid release via Ca2+ independent phospholipase A2
###end article-title 123
###begin article-title 124
###xml 115 118 <span type="species:ncbi:10116">rat</span>
Possible involvement of Ca2+-independent phospholipase A2 in protease-activated receptor-2-mediated contraction of rat urinary bladder
###end article-title 124
###begin article-title 125
Protease-activated receptors: how proteases signal to cells to cause inflammation and pain
###end article-title 125
###begin article-title 126
Proteinase-activated receptors, targets for kallikrein signaling
###end article-title 126
###begin article-title 127
Integrative control of the lower urinary tract: preclinical perspective
###end article-title 127
###begin article-title 128
Proteinase-activated receptors: novel mechanisms of signaling by serine proteases
###end article-title 128
###begin article-title 129
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
The inflammatory and normal transcriptome of mouse bladder detrusor and mucosa
###end article-title 129
###begin article-title 130
Connective molecular pathways of experimental bladder inflammation
###end article-title 130
###begin article-title 131
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Neurokinin 1 receptors and neprilysin modulation of mouse bladder gene regulation
###end article-title 131
###begin article-title 132
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation
###end article-title 132
###begin article-title 133
Multiple pathways of cell invasion are regulated by multiple families of serine proteases
###end article-title 133
###begin article-title 134
von Hippel-Lindau tumor suppressor protein stimulation by thrombin involves RhoA activation
###end article-title 134
###begin article-title 135
Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis
###end article-title 135
###begin article-title 136
Thrombin receptor expression is upregulated in prostate cancer
###end article-title 136
###begin article-title 137
Protease-activated receptor 1: a role in prostate cancer metastasis
###end article-title 137
###begin article-title 138
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors
###end article-title 138
###begin article-title 139
###xml 55 63 <span type="species:ncbi:9606">patients</span>
An antiproliferative factor from interstitial cystitis patients is a frizzled 8 protein-related sialoglycopeptide
###end article-title 139
###begin article-title 140
###xml 11 16 <span type="species:ncbi:9606">human</span>
Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment
###end article-title 140
###begin article-title 141
Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?
###end article-title 141
###begin article-title 142
Signal transduction. Decoding NF-kappaB signaling
###end article-title 142
###begin article-title 143
Oscillations in NF-kappaB signaling control the dynamics of gene expression
###end article-title 143
###begin article-title 144
Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo
###end article-title 144
###begin article-title 145
Allograft inflammatory factor-1 (AIF-1) is crucial for the survival and pro-inflammatory activity of macrophages
###end article-title 145
###begin article-title 146
Structural basis fortetraspanin functions as revealed by the cryo-EM structure of uroplakin complexes at 6-A resolution
###end article-title 146
###begin article-title 147
Origin of the tetraspanin uroplakins and their co-evolution with associated proteins: Implications for uroplakin structure and function
###end article-title 147
###begin article-title 148
Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking
###end article-title 148
###begin article-title 149
What determines differentiation of urothelial umbrella cells?
###end article-title 149
###begin article-title 150
Bladder permeability barrier: recovery from selective injury of surface epithelial cells
###end article-title 150
###begin article-title 151
Altered phenotype of cultured urothelial and other stratified epithelial cells: implications for wound healing
###end article-title 151
###begin article-title 152
Distinct glycan structures of uroplakins Ia and Ib: structural basis for the selective binding of FimH adhesin to uroplakin Ia
###end article-title 152
###begin article-title 153
###xml 14 24 <span type="species:ncbi:10141">guinea pig</span>
Disruption of guinea pig urinary bladder permeability barrier in noninfectious cystitis
###end article-title 153
###begin article-title 154
Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression
###end article-title 154
###begin article-title 155
Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells
###end article-title 155
###begin article-title 156
Urokinase-Receptor (u-PAR): An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/Dormancy, Clinical Outcome and Minimal Residual Disease
###end article-title 156
###begin article-title 157
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
###end article-title 157
###begin article-title 158
Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1
###end article-title 158
###begin article-title 159
###xml 92 96 <span type="species:ncbi:10090">mice</span>
Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock
###end article-title 159
###begin article-title 160
Relative contribution of G-protein-coupled pathways to protease-activated receptor-mediated Akt phosphorylation in platelets
###end article-title 160
###begin article-title 161
###xml 70 75 <span type="species:ncbi:9606">human</span>
Characterization and functional activity of thrombin receptors in the human lens
###end article-title 161
###begin article-title 162
Akt activation in platelets depends on Gi signaling pathways
###end article-title 162
###begin article-title 163
Arf6-independent GPI-anchored protein-enriched early endosomal compartments fuse with sorting endosomes via a Rab5/phosphatidylinositol-3'-kinase-dependent machinery
###end article-title 163
###begin article-title 164
Protease-activated receptor 2: activation, signalling and function
###end article-title 164
###begin article-title 165
Intracellular trafficking of hormone receptors
###end article-title 165
###begin article-title 166
TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k
###end article-title 166
###begin article-title 167
Ubiquitin and endocytic protein sorting
###end article-title 167
###begin article-title 168
Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2
###end article-title 168
###begin article-title 169
A role for the Rab6A' GTPase in the inactivation of the Mad2-spindle checkpoint
###end article-title 169
###begin article-title 170
The Rab6 GTPase regulates recruitment of the dynactin complex to Golgi membranes
###end article-title 170
###begin article-title 171
ARF proteins: roles in membrane traffic and beyond
###end article-title 171
###begin article-title 172
Localization and function of Arf family GTPases
###end article-title 172
###begin article-title 173
Multiple activities for Arf1 at the Golgi complex
###end article-title 173
###begin article-title 174
Constitutive endocytosis of the metabotropic glutamate receptor mGluR7 is clathrin-independent
###end article-title 174
###begin article-title 175
Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells
###end article-title 175
###begin article-title 176
Protease-activated receptor-2 regulates vascular endothelial growth factor expression in MDA-MB-231 cells via MAPK pathways
###end article-title 176
###begin article-title 177
###xml 138 143 <span type="species:ncbi:9606">human</span>
The agonist of the protease-activated receptor-1 (PAR) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human smooth muscle cells
###end article-title 177
###begin article-title 178
###xml 111 116 <span type="species:ncbi:9606">human</span>
Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells
###end article-title 178
###begin article-title 179
Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation
###end article-title 179
###begin article-title 180
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Biological consequences of thrombin receptor deficiency in mice
###end article-title 180
###begin article-title 181
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data
###end article-title 181
###begin article-title 182
###xml 54 57 <span type="species:ncbi:10116">rat</span>
Gene expression profiling of the left ventricles in a rat model of intrinsic aerobic running capacity
###end article-title 182
###begin article-title 183
Proteinase-activated receptors
###end article-title 183
###begin article-title 184
Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator
###end article-title 184
###begin title 185
Figures and Tables
###end title 185
###begin p 186
###xml 0 23 0 23 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. PAR1-dependent genes</bold>
###xml 132 136 132 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 419 423 419 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">mice</span>
A. PAR1-dependent genes. Inflammation was induced by intravesical instillation of substance P or LPS into the bladder of WT and PAR1-/- mice and compared to control (saline-treated); see methods for details. Twenty-four hours after, bladders were removed and the RNA was isolated for cDNA array experiments. Genes that were upregulated in response to inflammation in wild type mice and failed to be up-regulated in PAR1-/- mice were considered to be PAR-1 dependent transcripts. PAR-1 dependent transcripts were used to query the Ingenuity Pathways Analysis [IPA] and based on EntrezGene and Gene Ontology annotations were distributed into relevant biological compartments and biological interactions.
###end p 186
###begin p 187
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Participation of PAR1-dependent genes in canonical pathways</bold>
Participation of PAR1-dependent genes in canonical pathways. The experimental datasets of PAR1-dependent genes was used to query the Ingenuity Pathways Analysis [IPA] and overlaid to canonical pathways.
###end p 187
###begin p 188
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Primary functions associated with PAR1-dependent genes</bold>
Primary functions associated with PAR1-dependent genes. The experimental datasets of PAR1-dependent genes was used to query the Ingenuity Pathways Analysis [IPA] and overlaid with primary functions and diseases.
###end p 188
###begin p 189
Functions and disease shared by PAR1-depend transcripts.
###end p 189
###begin p 190
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-Based Assays</bold>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
Target validation by Q-PCR of Chromatin Immunoprecipitation (CHIP)-Based Assays. For target validation, female C57BL/6J mice (n = 20 per group) were instilled with 200 mul of one of the following substances: control inactive peptide (LRGILS [94]) or PAR-activating peptides (PAR1-AP = SFFLRN [94]; PAR2-AP = SLIGRL [94]). Twenty-four hours after instillation, bladders were removed and frozen. Bladders were exposed briefly to formaldehyde for cross-linking of the proteins and DNA together, followed by sonication to fragment the DNA. An antibody against RNA polymerase II (Abcam) was then used to precipitate the DNA transcriptome that was isolated and then purified using phenol extraction and EtOH precipitation. The final CHIP DNAs were then used as templates for Q-PCR reactions using primer pairs specific for each gene of interest, additional material 2 (Table 2). Q-PCRs were run in triplicate and the averaged Ct values were transferred into copy numbers of DNA using a standard curve of genomic DNA with known copy numbers. The resulting transcription values for each gene were also normalized for primer pair amplification efficiency using the Q-PCR values obtained with Input DNA (un-precipitated genomic DNA). Results are presented as "transcription events detected per 1000 cells" for each gene tested. Error bars correspond to standard deviations from the triplicate Q-PCR reactions. Control represents an un-transcribed region of the genome. Asterisks indicate a statistical significant difference (p < 0.05).
###end p 190
###begin p 191
###xml 36 38 36 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink">PAR-APs induce up-regulation of iPLA<sub>2 </sub>in the mouse urinary bladder</bold>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
PAR-APs induce up-regulation of iPLA2 in the mouse urinary bladder. Cytoplasmic extract from the bladder mucosa of wild type mice instilled with PAR-APs- or control peptide were subjected to Western Blot analysis to measure relative concentration of iPLA2. Results are representative of four separate experiments.
###end p 191
###begin p 192
###xml 68 70 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
Average densitometric values of PAR-APs induce up-regulation of iPLA2 in the mouse urinary bladder (Figure 6).
###end p 192

